Interpretation of biochemical testing in the neonatal period is challe
nging because of the complexity of perinatal physiology, the difficult
y of establishing appropriate laboratory reference ranges, and the tec
hnical aspects of analyzing microvolume specimens that are often hemol
yzed, lipemic, or have a high hematocrit or bilirubin concentration. M
etabolic problems such as hyperbilirubinemia and hypoglycemia in the f
ull-term neonate occur as the infant adapts from an intrauterine metab
olism to extrauterine life. Pathophysiological processes in the premat
ure infant vary with the severity of prematurity and the immaturity of
metabolic systems. Interpreting neonatal biochemistry requires age- a
nd gestation-specific reference ranges but technical, ethical, and phi
losophical concerns continue to impair the development of the needed r
eference data.